Kaur H, Thakur A, Kaur S
Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, India.
Parasite Immunol. 2015 Apr;37(4):192-203. doi: 10.1111/pim.12176.
A substantial number of antigens of Leishmania donovani have been described in the past. However, identifying candidate antigens is not enough. Appropriate antigen delivery to induce the right type of immune response against leishmaniasis (i.e. induction of a strong antigen-specific Th1 type of immune response) is another crucial component of an effective vaccine. Therefore, 'cocktail' vaccines are proposed based on the assumption that such cocktails will show enhanced efficacy. Studies have been carried out on LD31 and LD51 polypeptides from L. donovani promastigotes, which have proven to be potential vaccine candidates. This study was designed to check the protective efficacy of various cocktails of low molecular weight antigens alone and along with saponin as adjuvant. Mice were sacrificed on different post-challenge days for evaluation of parasite load and other immunological parameters. Protective efficacy of different vaccine formulations was revealed by significant decline in parasite burden and increased DTH Delayed Type Hypersenstivity responses. The antibody response was of IgG type with elevated IgG2a and decreased production of IgG1, whereas cytokine levels pointed towards the generation of protective Th1 type of immune response. Among all vaccine formulations, cocktail of 31+51+saponin was found to be highly immunogenic and imparted maximum protection.
过去已经描述了大量杜氏利什曼原虫的抗原。然而,仅仅识别候选抗原是不够的。将合适的抗原递呈以诱导针对利什曼病的正确类型的免疫反应(即诱导强烈的抗原特异性Th1型免疫反应)是有效疫苗的另一个关键组成部分。因此,基于此类混合疫苗将显示出更高疗效的假设,提出了“混合”疫苗。已经对来自杜氏利什曼原虫前鞭毛体的LD31和LD51多肽进行了研究,这些多肽已被证明是潜在的疫苗候选物。本研究旨在检测单独的各种低分子量抗原混合物以及与皂苷作为佐剂一起使用时的保护效力。在攻毒后的不同天数处死小鼠,以评估寄生虫负荷和其他免疫学参数。不同疫苗制剂的保护效力通过寄生虫负荷的显著下降和迟发型超敏反应(DTH)的增加得以体现。抗体反应为IgG型,IgG2a升高,IgG1产生减少,而细胞因子水平表明产生了保护性的Th1型免疫反应。在所有疫苗制剂中,31 + 51 +皂苷混合物被发现具有高度免疫原性并提供了最大程度的保护。